Back to User profile » Dr Gary T Ferguson

Papers published by Dr Gary T Ferguson:


Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease

Ohar JA, Ferguson GT, Mahler DA, Drummond MB, Dhand R, Pleasants RA, Anzueto A, Halpin DMG, Price DB, Drescher GS, Hoy HM, Haughney J, Hess MW, Usmani OS

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:79-92

Published Date: 6 January 2022

Peak Inspiratory Flow Rate in COPD: An Analysis of Clinical Trial and Real-World Data

Anderson M, Collison K, Drummond MB, Hamilton M, Jain R, Martin N, Mularski RA, Thomas M, Zhu CQ, Ferguson GT

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:933-943

Published Date: 12 April 2021

Unreported and Overlooked: A Post Hoc Analysis of COPD Symptom-Related Attacks from the RISE Study

Ferguson GT, Skärby T, Nordenmark LH, Lamarca R, Aksomaityte A, Lythgoe D, Gilbert I, Trudo F

International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:3123-3134

Published Date: 27 November 2020

Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD

Ichinose M, Fukushima Y, Inoue Y, Hataji O, Ferguson GT, Rabe KF, Hayashi N, Okada H, Takikawa M, Bourne E, Ballal S, DeAngelis K, Aurivillius M, Reisner C, Dorinsky P

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2993-3002

Published Date: 23 December 2019

Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study

Ichinose M, Fukushima Y, Inoue Y, Hataji O, Ferguson GT, Rabe KF, Hayashi N, Okada H, Takikawa M, Bourne E, Ballal S, DeAngelis K, Aurivillius M, Dorinsky P, Reisner C

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2979-2991

Published Date: 23 December 2019

Two-Year Integrated Efficacy And Safety Analysis Of Benralizumab In Severe Asthma

FitzGerald JM, Bleecker ER, Bourdin A, Busse WW, Ferguson GT, Brooks L, Barker P, Martin UJ

Journal of Asthma and Allergy 2019, 12:401-413

Published Date: 9 December 2019

Single-Use Autoinjector Functionality And Reliability For At-Home Administration Of Benralizumab For Patients With Severe Asthma: GRECO Trial Results

Ferguson GT, Cole J, Aurivillius M, Roussel P, Barker P, Martin UJ

Journal of Asthma and Allergy 2019, 12:363-373

Published Date: 23 October 2019

Effects of baseline symptom burden on treatment response in COPD

Martinez FJ, Abrahams RA, Ferguson GT, Bjermer L, Grönke L, Voß F, Singh D

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:181-194

Published Date: 4 January 2019

Assessment of an accessorized pre-filled syringe for home-administered benralizumab in severe asthma

Ferguson GT, Mansur AH, Jacobs JS, Hebert J, Clawson C, Tao W, Wu Y, Goldman M

Journal of Asthma and Allergy 2018, 11:63-72

Published Date: 5 April 2018